Meta-analysis of 2 RCTs (606 randomised, 590 analysed) in non-muscle-invasive bladder cancer: urinary biomarker-guided surveillance cut cystoscopy use by 55.8–74.9% vs standard cystoscopy, with no significant difference in recurrence (RR 1.04); non-inferiority not established.
Meta-analysisn = 606
Abushamma et al. Urinary biomarker-guided surveillance versus standard cystoscopic surveillance for non-muscle-invasive bladder cancer: a systematic review and meta-analysis of randomized controlled trials